Skip to main content
. 2015 Nov 30;3(1):13–18. doi: 10.2217/hep.15.35

Table 1. . Predictive scores for hepatocellular carcinoma risk.

Population Variables Validation Ref.
Chronic hepatitis B Age, gender, HBV DNA cirrhosis, core promoter mutation No [11]

Chronic hepatitis B Age, albumin, bilirubin, HBV DNA, cirrhosis (yes or no) Variable results in European and North American populations [12,13]

Chronic hepatitis B Age, ALT, HBeAg status, gender, HBV DNA Yes (only in Asia) [16]

Chronic hepatitis B Age, albumin, HBV DNA, liver stiffness by Fibroscan No [13]

Chronic hepatitis B Age, gender, ALT, HBV DNA, quantitative HBsAg, HBV genotype, HBe status No [17]

Chronic hepatitis C F3 and F4 Age, race, alkaline phosphatase, esophageal varices, smoking, platelets   [21]

Hepatitis C cirrhosis ALT, AFP, age platelets No [23]

General population Age, gender, alcohol consumption, BMI, diabetes (yes or no), coffee consumption, hepatitis B, hepatitis C No [31]

Liver transplant waitlist Age, diabetes, race, etiology of liver disease, sex, severity (CTP score) Yes [24]

General population Age, gender, ALT, liver disease, family history of HCC, cumulative smoking history No [27]

HCV post-SVR Age, gender, platelet count, AFP, fibrosis stage HCV genotype   [32]